| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/16/2009 | WO2009088064A1 IMPROVED HUMANIZED ANTI-HUMAN α9-INTEGRIN ANTIBODY |
| 07/16/2009 | WO2009088032A1 Antibody directed against pcrv |
| 07/16/2009 | WO2009087978A1 Anti-cldn6 antibody |
| 07/16/2009 | WO2008146019A8 Method for baculovirus generation from insect cells in high-troughput plates |
| 07/16/2009 | WO2008140353A8 AGENT EXHIBITING PROPERTIES TO FORM THE CELLULAR IMMUNITY AGAINST MYCOBACTERIUM TUBERCULOSIS H37 Rv, METHOD FOR THE PRODUCTION THEREOF (VARIANTS), A RECOMBINANT STRAIN AND AN AGENT FOR TUBERCULOSIS DIAGNOSIS |
| 07/16/2009 | WO2008040111A8 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 07/16/2009 | WO2007148092A8 In vitro protein expression process comprising cκ fusion molecules |
| 07/16/2009 | WO2003051720A3 A myeloma cell line useful for manufacturing recombinant proteins in chemically defined media |
| 07/16/2009 | US20090183285 Novel Bacillus Thuringiensis Gene with Coleopteran Activity |
| 07/16/2009 | US20090183282 Insecticidal compounds and methods for selection thereof |
| 07/16/2009 | US20090183278 Novel Bacillus Thuringiensis Gene with Coleopteran Activity |
| 07/16/2009 | US20090183277 Novel Bacillus Thuringiensis Gene with Coleopteran Activity |
| 07/16/2009 | US20090183276 Novel Bacillus Thuringiensis Gene with Coleopteran Activity |
| 07/16/2009 | US20090181912 GLP/1/EXENDIN 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES |
| 07/16/2009 | US20090181894 Chimeric toxins for targeted therapy |
| 07/16/2009 | US20090181875 Subtilase variants |
| 07/16/2009 | US20090181858 Adding photoregulated amino acids to the genetic code |
| 07/16/2009 | US20090181431 Fusion Proteins Between Plant Cell-Wall Degrading Enzymes, and Their Uses |
| 07/16/2009 | US20090181430 Protein folding |
| 07/16/2009 | US20090181429 Systems for the Expression of Orthogonal Translation Components Eubacterial Host Cells |
| 07/16/2009 | US20090181428 Method for producing target proteins using amino acids and pyruvic acids in culture of plant cells |
| 07/16/2009 | US20090181427 Hybrid 3' untranslated regions suitable for efficient protein expression in mammalian cells |
| 07/16/2009 | US20090181426 Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants |
| 07/16/2009 | US20090181425 Library of Translational Fusion Partners for Producing Recombinant Proteins and Translational Fusion Partners Screened Therefrom |
| 07/16/2009 | US20090181424 Mammalian Expression Vector Comprising the MCMV Promoter and First Intron of HCMV Major Immediate Early Gene |
| 07/16/2009 | US20090181423 Substantially animal protein-free recombinant furin and methods for producing same |
| 07/16/2009 | US20090181408 Flavin Adenine Dinucleotide-Binding Glucose Dehydrogenase |
| 07/16/2009 | US20090181382 Sphingosine 1-Phosphate Receptor Gene, SPPR |
| 07/16/2009 | US20090181153 Dry-Mill Ethanol Plant Extraction Enhancement |
| 07/16/2009 | US20090181116 Axmi-031, axmi-039, axmi-040 and axmi-049, a family of novel delta-endotoxin genes and methods for their use |
| 07/16/2009 | US20090181044 Novel Flavivirus antigens |
| 07/16/2009 | US20090181043 Method for Producing Human Anti-Thymocyte Immunoglobulins |
| 07/16/2009 | US20090181042 Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine |
| 07/16/2009 | US20090181041 Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof |
| 07/16/2009 | US20090181032 facilitate drug delivery of other molecules; e.g. use intraocularly in eye surgery, glaucoma, retinopathy treatments |
| 07/16/2009 | US20090181024 Novel composition and methods for the treatment of immune related diseases |
| 07/16/2009 | US20090181014 Compositions and methods for the diagnosis and treatment of tumor |
| 07/16/2009 | US20090181013 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 07/16/2009 | US20090181011 Compounds, Compositions and Methods for the Endocytic Presentation of Immunosuppressive Factors |
| 07/16/2009 | US20090181004 Modified beta-lactamase and method for its preparation |
| 07/16/2009 | US20090180995 Novel anticoagulant polypeptides and complex |
| 07/16/2009 | US20090180989 Compositions and methods for delivering nucleotide sequences to vertebrates |
| 07/16/2009 | CA2711882A1 Improved humanized anti-human .alpha.9-integrin antibody |
| 07/16/2009 | CA2711863A1 Antibody directed against pcrv |
| 07/16/2009 | CA2711771A1 Humanized anti-a9 integrin antibodies and the uses thereof |
| 07/16/2009 | CA2711557A1 Anti-cldn6 antibody |
| 07/16/2009 | CA2711307A1 Glycosylated protein expression in prokaryotes |
| 07/16/2009 | CA2710260A1 Substantially animal protein-free recombinant furin and methods for producing same |
| 07/16/2009 | CA2710253A1 Method of treating erythropoietin hyporesponsive anemias |
| 07/15/2009 | EP2078731A1 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient |
| 07/15/2009 | EP2078455A1 Plant cell having animal-type sugar chain adding function |
| 07/15/2009 | EP2078091A2 CRYSTALS AND STRUCTURE OF HUMAN IgG Fc VARIANT |
| 07/15/2009 | EP2078084A1 Glucanotransferase |
| 07/15/2009 | EP2078075A2 Random homozygous gene perturbation to enhance antibody production |
| 07/15/2009 | EP2078040A2 Hybrid immunoglobulins with moving parts |
| 07/15/2009 | EP2006305A9 Modified antibody with enhanced bioactivity |
| 07/15/2009 | EP1987142A4 Esterases and related nucleic acids and methods |
| 07/15/2009 | EP1922412A4 Humanized antibody conjugates and related methods, assays, reagents, and kits |
| 07/15/2009 | EP1907561A4 Cell lines for expressing enzyme useful in the preparation of amidated products |
| 07/15/2009 | EP1874329B1 Blood pressure lowering protein hydrolysates |
| 07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 07/15/2009 | EP1115862B1 Cytokine receptor zalpha11 |
| 07/15/2009 | CN101484585A Production of sialylated N-glycans in lower eukaryotes |
| 07/15/2009 | CN101481724A Preparation and use of antibacterial peptide PMAP-23 monoclonal antibody |
| 07/15/2009 | CN101481723A Method for preparing collagen peptide by using common carp skin |
| 07/15/2009 | CN100513571C Recombinant helicobacter pylori catalase |
| 07/15/2009 | CN100513570C Regulation effect of conjugated frame transport protein ABC1 |
| 07/15/2009 | CN100513414C A system for antibody expression and assembly |
| 07/14/2009 | US7560613 Comprises nucleotide sequences coding trehalose-6-phosphate phosphatase for enhancing water stress tolerance in plants; tissue engineering |
| 07/14/2009 | US7560540 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction |
| 07/14/2009 | US7560535 Pharmacokinetics; glycosyltransferases; antibodies; immunoglobulins |
| 07/14/2009 | US7560534 For use in therapeutic and diagnostic procedures |
| 07/14/2009 | US7560529 Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence |
| 07/14/2009 | US7560441 Modified and stabilized GDF propeptides and uses thereof |
| 07/14/2009 | US7560439 Method for increasing the gene expression of transfected genes |
| 07/14/2009 | US7560287 Long wavelength engineered fluorescent proteins |
| 07/14/2009 | US7560281 Use of TGF beta superfamily antagonists to make dopaminergic neurons from embryonic stem cells |
| 07/14/2009 | US7560279 Method of proliferating human hepatocytes and method for obtaining human hepatocytes |
| 07/14/2009 | US7560265 Compositions for regulation of tumor necrosis factor-alpha |
| 07/14/2009 | US7560262 Polynucleotide sequences encoding alkaline α-galactosidases and methods of using same |
| 07/14/2009 | US7560261 Nucleic acid sequences encoding CEL II endonuclease |
| 07/14/2009 | US7560259 Transferase for use as evaluative tool in diagnosing/prediciting cell proliferative, neurodegenerative and arsenic metabolism disorders |
| 07/14/2009 | US7560251 Media for Clostridium bacterium |
| 07/14/2009 | US7560249 The substrate comprises a carbon source comprising ethanol and an inducer |
| 07/14/2009 | US7560247 Nucleic acids encoding anti-IL-12 antibodies, and methods of production |
| 07/14/2009 | US7560107 Antihemophilic factor for use in the treatment of blood disorders; corrects hemophilia in a patient deficient in factor VIII or having inhibitors to factor VIII |
| 07/14/2009 | CA2382302C A nucleic acid and encoding polypeptide for use in inhibiting tumor angiogenesis |
| 07/09/2009 | WO2009086309A2 Cell culture processes |
| 07/09/2009 | WO2009086132A2 Design of spacers to increase the expression of recombinant fusion proteins |
| 07/09/2009 | WO2009086125A2 Affinity tag nucleic acid and protein compositions, and processes for using same |
| 07/09/2009 | WO2009085135A2 Yeast strains for protein production |
| 07/09/2009 | WO2009084671A1 Human anti-α9 integrin antibody |
| 07/09/2009 | WO2009084481A1 Immunodetection assay for mycobacterium tuberculosis complex |
| 07/09/2009 | WO2007109697A8 The use of protein s fusion for protein solubilization |
| 07/09/2009 | US20090178161 Method for directing nucleic acids to plastids |
| 07/09/2009 | US20090178147 Glycosylation in avians |
| 07/09/2009 | US20090176969 Cloning genes from streptomyces cyaneogriseus subsp. noncyanogenus for biosynthesis of antibiotics and methods of use |
| 07/09/2009 | US20090176967 Conjugation of FVII |
| 07/09/2009 | US20090176966 Natural IGM Antibodies and Inhibitors Thereof |
| 07/09/2009 | US20090176707 Human signal peptide-containing proteins |